Archer Investment Corporation’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-11
Closed -$1.12K 1239
2025
Q4
$1.12K Hold
11
﹤0.01% 1047
2025
Q3
$602 Hold
11
﹤0.01% 1097
2025
Q2
$585 Hold
11
﹤0.01% 1069
2025
Q1
$476 Buy
11
+8
+267% +$405 ﹤0.01% 1050
2024
Q4
$169 Hold
3
﹤0.01% 1082
2024
Q3
$204 Sell
3
-6
-67% -$339 ﹤0.01% 1043
2024
Q2
$380 Hold
9
﹤0.01% 1015
2024
Q1
$622 Buy
9
+3
+50% +$190 ﹤0.01% 982
2023
Q4
$444 Buy
+6
New +$393 ﹤0.01% 1006
2021
Q2
Sell
-20
Closed -$2.64K 601
2021
Q1
$2.64K Buy
+20
New +$2.74K ﹤0.01% 661

Other funds holding EXAS

Archer Investment Corporation's EXAS Position: Q1 2026 in Review

Archer Investment Corporation sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 11 shares — an estimated $1.12K sold.

Archer Investment Corporation first reported a position in EXAS in Q1 2021 and held it in 10 quarters. The position peaked at $2.64K in Q1 2021. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Archer Investment Corporation reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Archer Investment Corporation sold 11 Exact Sciences shares in Q1 2026, an estimated $1.12K.
  • Archer Investment Corporation first reported a position in Exact Sciences in Q1 2021 and held it in 10 quarters.
  • Archer Investment Corporation's Exact Sciences position peaked at $2.64K in Q1 2021.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Archer Investment Corporation's 13F filing for Q1 2026, filed 4 May 2026.